Our Free Live Online Webinar Series on RWE 2026–2027, Designing & Delivering Successful RWE Across Global Healthcare Systems, continues with its next country-focused session. 𝗗𝗲𝘀𝗶𝗴𝗻𝗶𝗻𝗴 & 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝗦𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗥𝗪𝗘 𝗔𝗰𝗿𝗼𝘀𝘀 𝗝𝗮𝗽𝗮𝗻 𝘄𝗶𝗹𝗹 𝘁𝗮𝗸𝗲 𝗽𝗹𝗮𝗰𝗲 𝗼𝗻 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆, 𝟮𝟰 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟲 𝗮𝘁 𝟱𝗽𝗺 𝗖𝗘𝗦𝗧. In this 60-minute session, Prof. Masao Iwagami, Clinical Epidemiologist and Professor at the University of Tsukuba and London School of Hygiene & Tropical Medicine, will share practical insights into Japan’s healthcare system, clinical practice patterns and real-world data landscape, including key hospital-based and administrative claims databases, their strengths, limitations and practical use in RWE study design and delivery. The session is particularly relevant for professionals working in pharmaceutical and medical device companies who are involved in real-world evidence, medical affairs, pharmacoepidemiology, observational research, HEOR, market access or evidence generation. Register here: https://lnkd.in/euqYpRqD We look forward to seeing you there. #RealWorldEvidence #RWE #HealthcareResearch #MedicalAffairs #Epidemiology #Pharmacoepidemiology #WebinarSeries
OXON Epidemiology
Research Services
London, England 10,177 followers
European CRO specialised in real-world evidence and observational research
About us
OXON Epidemiology is a European full-service Contract Research Organization (CRO) specialised in real-world evidence (RWE) and observational research across all major therapeutic areas. We design and deliver high-quality primary, secondary and hybrid data studies, including pragmatic trials, patient registries, synthesis research and advanced statistical modelling for drugs and medical devices. Our collaborative model—working closely with academic institutions and life sciences partners—ensures scientific rigour, regulatory compliance and operational excellence. We support clients across the product lifecycle, providing robust evidence to inform regulatory submissions, safety evaluations, health economics and strategic decision-making. Core areas of expertise: • Multi-country field, chart review and database epidemiological studies • Patient registries and pragmatic trials • PASS and PAES studies • Risk management and risk minimisation studies • Statistical signal detection and benefit-risk analysis (CTD / PBRER) • Patient-reported outcomes (PROs) • Health economics and outcomes research (HEOR) • Systematic reviews, meta-analyses and evidence strategy • Data integration and quantitative modelling Through the integration of quality science and operational expertise, OXON Epidemiology contributes to advancing patient care and public health worldwide.
- Website
-
http://www.oxonepi.com
External link for OXON Epidemiology
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2008
- Specialties
- Real-World Evidence (RWE), Observational Research, Epidemiology, Patient Registries, PASS & PAES Studies, Risk Management & Risk Minimisation, Health Economics & Outcomes Research (HEOR), Patient-Reported Outcomes (PROs), Systematic Reviews & Meta-Analyses, Evidence Strategy, Statistical & Decision Modelling, Primary Data Collection Studies, Secondary Database Studies, Hybrid Study Designs, Regulatory-Compliant Observational Research, and Complex Study Design & Protocol Development
Locations
-
Primary
Get directions
200 Northcote Road
London, England CR0 2, GB
-
Get directions
Calle Dr. Fleming 51
Madrid, Madrid 28036, ES
Employees at OXON Epidemiology
Updates
-
OXON Epidemiology reposted this
We are pleased to launch our new Free Live Online Webinar Series on RWE 2026–2027: Designing & Delivering Successful RWE Across Global Healthcare Systems. Our first session, Designing & Delivering Successful RWE Across France, will take place on Thursday, 21 May 2026 at 5pm CEST. In this 60-minute session, Dr Patrick Blin, Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of CESREES, will share practical insights into the healthcare system in France, the use of real-world data sources, and the role of the Système National des Données de Santé (SNDS), one of the largest nationwide healthcare databases globally. Register here: https://lnkd.in/eynKYWmw We look forward to seeing you there. #RealWorldEvidence #RWE #HealthcareResearch #MedicalAffairs #Epidemiology #Pharmacoepidemiology #WebinarSeries
-
-
We are pleased to launch our new Free Live Online Webinar Series on RWE 2026–2027: Designing & Delivering Successful RWE Across Global Healthcare Systems. Our first session, Designing & Delivering Successful RWE Across France, will take place on Thursday, 21 May 2026 at 5pm CEST. In this 60-minute session, Dr Patrick Blin, Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of CESREES, will share practical insights into the healthcare system in France, the use of real-world data sources, and the role of the Système National des Données de Santé (SNDS), one of the largest nationwide healthcare databases globally. Register here: https://lnkd.in/eynKYWmw We look forward to seeing you there. #RealWorldEvidence #RWE #HealthcareResearch #MedicalAffairs #Epidemiology #Pharmacoepidemiology #WebinarSeries
-
-
We're #hiring a new Senior Statistician in Madrid, Community of Madrid. Apply today or share this post with your network.
-
OXON Epidemiology reposted this
✨✨ Alhamdolillah another paper accepted in Q1 journal, IF:3.1. 🔹Journal of Epidemiology and Global Health* *Trends and Disparities in Ischemic Heart Disease and Pneumonia Associated Mortality in the United States: A Population-Based Retrospective Analysis of Death Records From 1999 to 2023* OXON Epidemiology Epidemiology, Biostatistics & Occupational Health Epidemiology Infection Control and Hospital Epidemiology International Doctoral Programme in Epidemiology and Public Health (IPPE) King Abdullah International Medical Research Center (كيمارك KAIMRC) Al Ain University Ajman University HKUMed – The University of Hong Kong Korean Studies, Monash University University of Tasmania Victoria University Université Laval University of Toronto The University of British Columbia UCalgary Faculty of Science McMaster University University of Ottawa Princess Nourah Bint Abdulrahman University Parc des Princes - Campus PSG - Événements BtoB IHU LIRYC - Heart rhythm disease Institute The Journal Of Heart Valve Disease The Lancet Primary Care NUS Yong Loo Lin School of Medicine Ministry of Health Oman
-
𝗙𝗥𝗘𝗘 𝗟𝗜𝗩𝗘 𝗪𝗘𝗕𝗜𝗡𝗔𝗥 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 Can real-time pharmacovigilance accelerate regulatory approval and reimbursement? Traditional routes to marketing authorisation can be slow and may miss long-term real-world safety and effectiveness. Join this live expert-led session to discover how validated, real-time RWE systems support early access, continuous monitoring, and evidence generation beyond clinical trials. 𝗗𝗮𝘁𝗲: 26 February 2026 𝗧𝗶𝗺𝗲: 5pm CET | 4pm UK | 11am EST | 8am PST 𝗗𝘂𝗿𝗮𝘁𝗶𝗼𝗻: 90 minutes 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺: GoToWebinar 𝗪𝗵𝗮𝘁 𝘄𝗲 𝘄𝗶𝗹𝗹 𝗰𝗼𝘃𝗲𝗿: • Current challenges in regulatory approval and reimbursement • How real-time RWE pharmacovigilance supports regulatory approval • Hierarchical vs conventional composite endpoints • How RWE supports reimbursement decisions • How the OXON–SafeMed collaboration accelerates approval pathways • Live SafeMed system demonstration + Q&A Featuring: Professor Thomas MacDonald (University of Dundee) Dr Nawab Qizilbash (LSHTM) Krists Zutis (CTO, SafeMed) This webinar is particularly relevant for professionals in Pharmacovigilance, Safety, Real-World Evidence, Clinical Development, Medical Affairs, HEOR, Market Access and Regulatory Affairs. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗵𝗲𝗿𝗲: https://lnkd.in/emhKSK4h #Pharmacovigilance #RealWorldEvidence #RWE #DrugSafety #RegulatoryAffairs #MedicalAffairs #HEOR #MarketAccess #ClinicalDevelopment #LifeSciences
-
-
We’re excited to welcome Ankit Sharma to OXON Epidemiology as Head of Business Development. With more than 15 years of experience including real-world evidence and late-phase research, Ankit strengthens our ability to support our clients through trusted, data-driven solutions. He will play a key role in our continued growth and in building strong, long-term partnerships, working closely with our teams to help deliver evidence that supports informed decision-making. We’re really looking forward to working together as a team and to what’s ahead. Welcome to OXON, Ankit! #OXONEpidemiology #WelcomeToTheTeam #BusinessDevelopment #LifeSciences #RealWorldEvidence #ObservationalStudies
-
-
As 2025 draws to a close, we would like to thank our clients, partners and colleagues for their continued trust and partnership throughout the year. Behind every milestone, there has been a shared effort, day-to-day teamwork, open dialogue and a genuine commitment to doing things well. We truly appreciate the part you have played in that, and we look forward to continuing in the same spirit in 2026. Season’s greetings from all of us at OXON Epidemiology, and best wishes for a healthy and inspiring 2026. #SeasonGreetings #Welcome2026 #MerryChristmas #HappyNewYear
-
-
OXON Epidemiology will be a Gold Partner at the 18th Annual #MedAffairsTransformation Conference in Zürich on 6 November 2025. If you are attending, don’t miss our presentation “Making Real-World Data Work for Medical Affairs: From Evidence to Impact,” featuring Bélène Podrnore and Alicia Delibes with Prof. Stuart Pocock and Dr Nawab Qizilbash, joining online. We’ll share practical examples of how RWE enhances Medical Affairs strategy, from bridging trial and real-world evidence to accelerating high-quality data for publications, congresses, and stakeholder engagement. And visit our booth! As a Real-World Evidence CRO, we design and deliver global RWE studies, pragmatic trials, and evidence synthesis, transforming data into actionable insight that drives Medical Affairs impact. Our team can help you strengthen your evidence generation strategy. #MedAffairs2025 #MedAffairsTransformation #MedicalAffairs #RealWorldEvidence #RWE #EvidenceGeneration #LifeSciences #Pharma #HealthcareInnovation #OXONEpidemiology
-